Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CPRX
CPRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CPRX News
Catalyst Pharmaceuticals to Announce Q1 Earnings on May 11
20h ago
seekingalpha
Monteverde Law Firm Investigates Catalyst Pharmaceuticals Sale
6h ago
Globenewswire
Catalyst Pharmaceuticals Agrees to $4.1B Acquisition by Angelini Pharma
1d ago
Yahoo Finance
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
2d ago
PRnewswire
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
4d ago
NASDAQ.COM
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
4d ago
Globenewswire
Hetero Labs Secures License for FIRDAPSE Generic
4d ago
Newsfilter
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
4d ago
Newsfilter
Italy's Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
4d ago
Newsfilter
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1B
4d ago
seekingalpha
Catalyst Pharmaceuticals Settles Patent Litigation with Hetero Labs
4d ago
Yahoo Finance
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
4d ago
Globenewswire
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $31.50 Per Share in $4.1 Billion Transaction
4d ago
moomoo
Angelini Pharma Evaluates Potential Acquisition of Catalyst Pharmaceuticals
Apr 27 2026
seekingalpha
Catalyst Pharmaceuticals Reports Record Revenues and Strong Growth Outlook for 2026
Feb 26 2026
seekingalpha
Halozyme and Catalyst Report Double-Digit Revenue Growth, Strong Outlook
Jan 24 2026
NASDAQ.COM
Show More News
